Evidence map›Paper›PMID 32449012›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2020

Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis.

José A G Agúndez, Elena García-Martín, Christopher Rodríguez, Julián Benito-León, Jorge Millán-Pascual, María Díaz-Sánchez, Patricia Calleja, Laura Turpín-Fenoll, Hortensia Alonso-Navarro, Esteban García-Albea and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Oxidative Stress Markers in Multiple Sclerosis.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Association betweenInternational journal of molecular sciences · 2022
    Article
  5. Genes · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

José A G AgúndezUNEx, ARADyAL Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.
Elena García-MartínUNEx, ARADyAL Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.
Christopher RodríguezUNEx, ARADyAL Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.
Julián Benito-LeónCIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
Jorge Millán-PascualSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain.
María Díaz-SánchezService of Neurology, Hospital Universitario Doce de Octubre, Madrid, Spain.
Patricia CallejaService of Neurology, Hospital Universitario Doce de Octubre, Madrid, Spain.
Laura Turpín-FenollSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain.
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, C/ Marroquina 14, 3º B, Arganda del Rey, 28030, Madrid, Spain.
Esteban García-AlbeaDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
José Francisco Plaza-NietoSection of Neurology, Hospital Universitario del Sureste, C/ Marroquina 14, 3º B, Arganda del Rey, 28030, Madrid, Spain.
Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, C/ Marroquina 14, 3º B, Arganda del Rey, 28030, Madrid, Spain. fjavier.jimenez@salud.madrid.org.ORCID 0000-0002-7558-7323
Instituto de Salud Carlos III · ESHospital Universitario 12 De Octubre · ESHospital Universitario del Sureste · ESHospital Universitario Príncipe de Asturias · ESUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The possible role of oxidative stress and nitric oxide (NO) in the pathogenesis of multiple sclerosis (MS) has been suggested by several neuropathological, biochemical, and experimental data. Because the single-nucleotide polymorphism (SNP) rs2070744 in the endothelial nitric oxide synthase (eNOS or NOS3) gene (chromosome 7q36.1) showed association with the risk for MS in Iranians, we attempted to replicate the possible association between this SNP and the risk for MS in the Caucasian Spanish population. The frequencies of NOS3rs2070744 genotypes and allelic variants in 300 patients diagnosed with MS and 380 healthy controls were assessed with a TaqMan-based qPCR assay. The possible influence of the genotype frequency on age at onset of MS, the severity of MS, clinical evolutive subtypes of MS, and HLA-DRB1*1501 genotype were also analyzed. The frequencies of rs2070744 genotypes and allelic variants were not associated with the risk of developing MS and were not influenced by gender, age at onset and severity of MS, the clinical subtype of MS or the HLA-DRB1*1501 genotype. This study found a lack of association between NOS3 rs2070744 SNP and the risk for MS in Caucasian Spanish people.

Indexed as

Multiple SclerosisNitric Oxide Synthase Type IIIGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansIranNitric OxidePolymorphism, Single NucleotideNitric OxideNitric Oxide Synthase Type IIINOS3 protein, humanGenetic polymorphismsGeneticsMultiple sclerosisNitric oxideNitric oxide synthase genesRisk factors

Identifiers

PMID32449012
OpenAlexW3027262801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.